NCT02923583View on ClinicalTrials.gov

Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

July 21, 2017

Study Completion Date

July 21, 2017

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

M834

BIOLOGICAL

US-Sourced Orencia®

BIOLOGICAL

EU-Sourced Orencia®

Trial Locations (2)

LS2 9LH

Covance Clincal Research Unit Ltd, Leeds

NW10 7EW

Hammersmith Medicines Research (HMR), London

Sponsors

Collaborators (1)

Mylan Inc.
All Listed Sponsors
collaborator

Mylan Inc.

INDUSTRY

lead

Momenta Pharmaceuticals, Inc.

INDUSTRY

NCT02923583 - Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects | Biotech Hunter | Biotech Hunter